Genetics, genomics, and cancer risk assessment

ACOG Practice Bulletin No. 103: Hereditary Breast and Ovarian Cancer Syndrome

(2014)   OBSTETRICS AND GYNECOLOGY

Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer

(2013) Ellen Warner et al.   ANNALS OF INTERNAL MEDICINE

Familial breast cancer: is it time to move from a reactive to a proactive role?

(2011) H. Harris et al.   Familial Cancer

Prospective Study of Breast Cancer Incidence in Women With aBRCA1orBRCA2Mutation Under Surveillance With and Without Magnetic Resonance Imaging

(2011) Ellen Warner et al.   JOURNAL OF CLINICAL ONCOLOGY

Development and Evaluation of a Decision Aid for BRCA Carriers with Breast Cancer

(2011) Julie O. Culver et al.   Journal of Genetic Counseling

Confirmation of Family Cancer History Reported in a Population-Based Survey

(2011) Phuong L. Mai et al.   JNCI-Journal of the National Cancer Institute

A decade’s perspective on DNA sequencing technology

(2011) Elaine R. Mardis   NATURE

Cancer genomics: from discovery science to personalized medicine

(2011) Lynda Chin et al.   NATURE MEDICINE

Ingredients for Success: A Familial Cancer Clinic in an Oncology Practice Setting

(2011) Paul R. Duncan et al.   Journal of Oncology Practice

A Clinical Scoring System for Selection of Patients for PTEN Mutation Testing Is Proposed on the Basis of a Prospective Study of 3042 Probands

(2010) Min-Han Tan et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Family History and Personal Genomics As Tools for Improving Health in an Era of Evidence-Based Medicine

(2010) Muin J. Khoury et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Primary care physicians' use of family history for cancer risk assessment

(2010) Brian S Flynn et al.   BMC Family Practice

Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population

(2010) T. A. Dinh et al.   Cancer Prevention Research

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

(2010) A. C. Antoniou et al.   CANCER RESEARCH

Estimating CDKN2A Carrier Probability and Personalizing Cancer Risk Assessments in Hereditary Melanoma Using MelaPRO

(2010) W. Wang et al.   CANCER RESEARCH

Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study

(2010) Noralane M. Lindor et al.   Familial Cancer

The PREMM1,2,6 Model Predicts Risk of MLH1, MSH2, and MSH6 Germline Mutations Based on Cancer History

(2010) Fay Kastrinos et al.   GASTROENTEROLOGY

Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry

(2010) Charles R. Jonassaint et al.   HUMAN GENETICS

Lessons Learned From Genetic Testing

(2010) Laura Esserman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Germline Epigenetic Regulation of KILLIN in Cowden and Cowden-like Syndrome

(2010) Kristi L. Bennett   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Breast Cancer Screening

(2010)   JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING

Clinical Implications of the Cancer Genome

(2010) Laura E. MacConaill et al.   JOURNAL OF CLINICAL ONCOLOGY

Genome-Wide Association Studies of Cancer

(2010) Zsofia K. Stadler et al.   JOURNAL OF CLINICAL ONCOLOGY

Expanding the Criteria forBRCAMutation Testing in Breast Cancer Survivors

(2010) Janice S. Kwon et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

(2010) Mark E. Robson et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models

(2010) E. Amir et al.   JNCI-Journal of the National Cancer Institute

Challenges in the clinical application of whole-genome sequencing

(2010) Kelly E Ormond et al.   LANCET

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

(2010) Andrew Tutt et al.   LANCET

Clinical assessment incorporating a personal genome

(2010) Euan A Ashley et al.   LANCET

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

(2010) M William Audeh et al.   LANCET

Point: Hypotheses first

(2010) Robert Weinberg   NATURE

Has the revolution arrived?

(2010) Francis Collins   NATURE

Genomic Medicine — An Updated Primer

(2010) W. Gregory Feero et al.   NEW ENGLAND JOURNAL OF MEDICINE

Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates

(2010) Sandra M. Brown et al.   PATIENT EDUCATION AND COUNSELING

1000 Genomes Project Gives New Map of Genetic Diversity

(2010) Elizabeth Pennisi   SCIENCE

Disclosure of individual genetic data to research participants: the debate reconsidered

(2010) Annelien L. Bredenoord et al.   TRENDS IN GENETICS

The $1,000 genome, the $100,000 analysis?

(2010) Elaine R Mardis   Genome Medicine

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

(2010) Mia M. Gaudet et al.   PLoS Genetics

Development and Validation of a Colon Cancer Risk Assessment Tool for Patients Undergoing Colonoscopy

(2009) Fay Kastrinos et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Genetic assessment of breast cancer risk in primary care practice

(2009) Wylie Burke et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care

(2009) Patricia Ashton-Prolla et al.   BMC CANCER

Electronic Health Records and the Management of Women at High Risk of Hereditary Breast and Ovarian Cancer

(2009) Brian Drohan et al.   Breast Journal

Cancer Prevention: From 1727 to Milestones of the Past 100 Years

(2009) Scott M. Lippman et al.   CANCER RESEARCH

Cancer genetic predisposition: information needs of patients irrespective of risk level

(2009) Alison Metcalfe et al.   Familial Cancer

Cancer Genetic Risk Assessment and Referral Patterns in Primary Care

(2009) Hetal S. Vig et al.   Genetic Testing and Molecular Biomarkers

Barriers to the use of genetic testing: A study of racial and ethnic disparities

(2009) Sandra Suther et al.   GENETICS IN MEDICINE

Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population

(2009) Cecelia A Bellcross et al.   GENETICS IN MEDICINE

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives

(2009)   GENETICS IN MEDICINE

The current state of cancer family history collection tools in primary care: a systematic review

(2009) Nadeem Qureshi et al.   GENETICS IN MEDICINE

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

(2009) Glenn E Palomaki et al.   GENETICS IN MEDICINE

Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: Impact on measures of decision making and satisfaction.

(2009) Marc D. Schwartz et al.   HEALTH PSYCHOLOGY

Genome-wide Association Studies and Human Disease

(2009) Peter M. Visscher et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ten Years After Mutation Testing for Lynch Syndrome: Cancer Incidence and Outcome in Mutation-Positive and Mutation-Negative Family Members

(2009) Heikki J. Järvinen et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

(2009) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families Withp53Germline Mutations

(2009) Kelly D. Gonzalez et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of the Health Belief Model for Predicting Intention to Pursue Genetic Testing for Colorectal Cancer

(2009) Amanda Cyr et al.   Journal of Genetic Counseling

Women’s Perceptions of the Personal and Family Impact of Genetic Cancer Risk Assessment: Focus Group Findings

(2009) Deborah J. MacDonald et al.   Journal of Genetic Counseling

Breast Cancer Single-Nucleotide Polymorphisms: Statistical Significance and Clinical Utility

(2009) Kenneth Offit   JNCI-Journal of the National Cancer Institute

An agenda for personalized medicine

(2009) Pauline C. Ng et al.   NATURE

Exome sequencing identifies the cause of a mendelian disorder

(2009) Sarah B Ng et al.   NATURE GENETICS

Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer

(2009) Fleur Huang et al.   Nature Reviews Clinical Oncology

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?

(2008) Catharina E. Jacobi et al.   BREAST CANCER RESEARCH AND TREATMENT

Association of Insurance with Cancer Care Utilization and Outcomes

(2008) E. Ward et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007

(2008) Gordon F. Schwartz et al.   CANCER

Too Many Referrals of Low-Risk Women for BRCA1/2 Genetic Services by Family Physicians

(2008) D. B. White et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians

(2008) Katrina J Lowstuter et al.   GENETICS IN MEDICINE

Genomic Profiles for Disease Risk

(2008) Kenneth Offit   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Improvement in Oncology Practice Performance Through Voluntary Participation in the Quality Oncology Practice Initiative

(2008) Joseph O. Jacobson et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinically Applicable Models to CharacterizeBRCA1andBRCA2Variants of Uncertain Significance

(2008) Andrew D. Spearman et al.   JOURNAL OF CLINICAL ONCOLOGY

Decision Making Regarding Prophylactic Mastectomy: Stability of Preferences and the Impact of Anticipated Feelings of Regret

(2008) Sandra van Dijk et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology Policy Statement: The Role of the Oncologist in Cancer Prevention and Risk Assessment

(2008) Robin T. Zon et al.   JOURNAL OF CLINICAL ONCOLOGY

Acculturation and Familiarity With, Attitudes Towards and Beliefs about Genetic Testing for Cancer Risk Within Latinas in East Harlem, New York City

(2008) Katarina M. Sussner et al.   Journal of Genetic Counseling

Standardized Human Pedigree Nomenclature: Update and Assessment of the Recommendations of the National Society of Genetic Counselors

(2008) Robin L. Bennett et al.   Journal of Genetic Counseling

Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis

(2008) Michael T Halpern et al.   LANCET ONCOLOGY

Interventions to improve risk communication in clinical genetics: Systematic review

(2008) A. Edwards et al.   PATIENT EDUCATION AND COUNSELING

Healthcare’s ascension to patient-centered genomic care

(2008) Steven AR Murphy et al.   Personalized Medicine

Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer

(2008) Veronica I. Lagos et al.   PSYCHO-ONCOLOGY

The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent

(2008) Katarina M. Sussner et al.   PSYCHO-ONCOLOGY

Increased Uptake of BRCA1/2 Genetic Testing Among African American Women With a Recent Diagnosis of Breast Cancer

(2007) Lisa R. Susswein et al.   JOURNAL OF CLINICAL ONCOLOGY